This study throws us a few more questions in addition to some of the answers it provided. As stated above, it would be interesting to explore whether higher LBMI in adolescence is a predictor for slow decline in lung function, thereby reducing the risk of adulthood respiratory disorders. Could lifestyle modifications that reduced fat mass and the FMI trajectory alter decline in lung function in later life? Does the variable strength of association of FMI to lower lung function between boys and girls demonstrate the preprogrammed risk of COPD in adult men to be higher than in women? Are there specific factors that influence lung function through the adolescent growth phase?
Community-acquired pneumonia (CAP) is the most common type of pneumonia and remains a leading cause of morbidity and mortality worldwide (1) (2) (3) . Although many different pathogens can contribute to pneumonia, Streptococcus pneumoniae is one of the common bacterial pathogens that underlie CAP (4) . In healthy individuals, despite frequent colonization of the upper airways by pathogenic bacteria, multiple innate mechanisms help to protect the lower airways, and CAP is relatively uncommon.
Alveolar macrophages (AMs) are long-lived resident innate immune cells of the airways and key effectors of antibacterial host defense against microbes. Previous work has illustrated that effective bacterial elimination by AMs proceeds in two separate phases: an initial period of macrophage viability and intracellular bacterial killing followed by a later induction of apoptosis and clearance of bacteria (5) . Although antimicrobicidal mechanisms contribute to early phagosomal killing of S. pneumoniae, AMs demonstrate a finite capacity for bacterial processing and must use a secondary mechanism to control infection. Although initially resistant to apoptosis, in the later phase, AMs use the induction of apoptosis to enhance S. pneumoniae killing and minimize inflammation (5) . The ability of AMs to make this transition from resistance to increased susceptibility to apoptosis is essential for effective host immune responses to S. pneumoniae.
Mcl-1 (myeloid cell leukemia sequence-1) is an essential regulator of macrophage lifespan and plays a key role in the switch from AM viability to apoptosis (5, 6) . Mcl-1 is located in mitochondrial-enriched cell fractions and can heterodimerize with proapoptotic Bcl-2 (B-cell lymphoma 2) family members to maintain mitochondrial homeostasis (7) . Recent work demonstrates that elevated Mcl-1 expression in AMs from patients at increased risk of CAP because of chronic obstructive pulmonary disease or HIV-1 infection is associated with reduced AM apoptosis and bacterial killing (8, 9) . In this issue of the Journal, Preston and colleagues (pp. 84-97) propose that Mcl-1 upregulation prevents macrophage apoptosis-associated killing of S. pneumoniae (10) . To examine the role of Mcl-1 in mediating bacterial clearance, Preston and colleagues design a transgenic mouse with macrophage-specific overexpression of human Mcl-1 (CD68.hMcl-1 1 ) (10). In a series of meticulously designed experiments, they use controlled infections and interventions to explore the role, microbicidal mechanism, and therapeutic reengagement of macrophage apoptosis-associated bacterial killing. The authors illustrate that Mcl-1 overexpression in macrophages does not alter the early induction of phagocytosisassociated phagolysomal killing. In contrast, late-phase intracellular killing, which coincides with macrophage-associated apoptosis at 16 to 20 hours, is blunted in macrophages overexpressing Mcl-1. Specifically, overexpression of Mcl-1 decreases caspase-dependent mitochondrial reactive oxygen species (mROS) production during the late phase of bacterial exposure, resulting in decreased apoptosisassociated bacterial killing. In response to an intermediate dose of S. pneumoniae, which represents the "tipping point" at which AMs begin to fail at controlling the infection, CD68.hMcl-1 1 transgenic mice exhibit a significant increase in bacterial burden accompanied by significant neutrophil recruitment. To investigate if reduced AM apoptosis-associated killing in CD68.hMcl-1 1 transgenic mice underlies impaired bacterial clearance, the authors use liposomes containing chlodronate to target AM or BH3 mimetics navitoclax (previously ABT-263) and sabutoclax to reengage macrophage apoptosis. Notably, reconstitution of AM apoptosis in CD68.hMcl-1 1 transgenic mice increases bacterial clearance from the lung, reduces bacterial levels in the blood, and decreases neutrophil recruitment.
The article by Preston and colleagues has several unique attributes (10) . First, the development and usage of a macrophage-specific CD68.hMcl-1 transgenic mouse provides a unique insight into the role and mechanism of macrophage apoptosis-associated bacterial killing in the lung. Although the relevance of animal models to human disease does merit careful dissection, it is important to note that the design and use of a murine model allowed the authors to test the impact of Mcl-1 overexpression in the context of early-stage subclinical infection. Second, they convincingly demonstrate that Mcl-1 limits caspase-dependent mROS generation and, in turn, decreases apoptosis-associated killing of S. pneumoniae. Decreased late-phase bacterial killing results in increased neutrophil recruitment, a hallmark feature of pneumonia. Third, they establish that apoptosis-associated killing is required for bacterial clearance, and reengagement of AM apoptosis can enhance S. pneumoniae clearance in lung.
Although this study is elegant in its design and execution, these findings bring up a number of questions for future investigations. Effective bacterial elimination by alveolar macrophages (AMs) proceeds in two separate phases: an initial period of macrophage viability and intracellular bacterial killing followed by a later induction of apoptosis and clearance of bacteria. During the initial phase, Mcl-1 (myeloid cell leukemia sequence-1) maintains mitochondrial homeostasis and AMs remain resistant to apoptosis. AMs demonstrate a finite capacity for bacterial processing, and, in the later phase, decreased Mcl-1 expression contributes to increased caspase 3/7 activation and increased mitochondrial reactive oxygen species (ROS) production. The ability of AMs to make this transition from resistance to increased susceptibility to apoptosis is essential for effective host immune responses to Streptococcus pneumoniae.
